Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers ...

Japan has approved two stem cell-based therapies for treating Parkinson's disease and heart failure in a world first, through ...

Physicians and scientists from Longevity Medical Institute® have published new peer-reviewed research examining the safety of allogeneic mesenchymal stem cell therapies across a broad range of human ...

The country has approved groundbreaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said, with the therapies expected to reach patients ...

On 6 March 2026, Japan approved the world’s first iPS stem cell treatments for Parkinson’s and severe heart failure. Could ...

An innovative stem cell therapy approved for severe heart failure has been cleared for use in Japan. Here is why it matters ...

Stem cells are gaining attention for their potential to treat leukemia, certain solid tumor cancers, and inherited metabolic ...

Japan has approved the world’s first stem cell therapy for Parkinson’s disease, offering new hope for millions globally. The treatment uses induced pluripotent stem (iPS) cells to replace damaged ...

Japan’s health ministry has endorsed two stem-cell therapies derived from induced pluripotent stem (iPS) cells, making them ...

LOS CABOS, BAJA CALIFORNIA SUR, Mexico, March 11, 2026 /PRNewswire/ -- Physicians and scientists from Longevity Medical Institute(R) have published new peer-reviewed research examining the therapeutic ...